Skip to main content
Terug
Watch Compare

ClearPoint Neuro, Inc.

Datakwaliteit: 100%
CLPT
NASDAQ Manufacturing Measuring & Analyzing Instruments
€ 8,68
▼ € 0,28 (-3,13%)
Marktkapitalisatie: 267,14 M
Prijs
€ 8,98
Marktkapitalisatie
267,14 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 22,72% annually over 5 years — strong growth
Negative free cash flow of -24,45 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,94%
Capital efficient — spends only 1,41% of revenue on capex

Groei

Revenue Growth (5Y)
22,72%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)17,78%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-143,41%
Onder sectorgemiddelde (-53,58%)
ROIC-35,42%
Net Margin-69,08%
Op. Margin-65,36%

Veiligheid

Debt / Equity
1,84
Boven sectorgemiddelde (0,30)
Current Ratio6,37
Interest Coverage-10,12

Waardering

PE (TTM|NTM)
-10,46 | -10,65
Onder sectorgemiddelde (-1,48)
P/B Ratio16,83
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -10,5 -1,5
P/B 16,8 1,6
ROE % -143,4 -53,6
Net Margin % -69,1 -41,5
Rev Growth 5Y % 22,7 1,8
D/E 1,8 0,3

Koersdoel Analisten

2 analisten
Buy
Huidig
€ 8,68
+188.0%
Koersdoel
€ 25,00
€ 20,00
€ 25,00
€ 30,00
Vooruitzicht
Forward K/W -10,65
Forward WPA -€ 0,82
Omzet Sch. 63,10 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,82
-€ 0,88 – -€ 0,75
 63,10 M 2
FY2026 -€ 0,97
-€ 0,98 – -€ 0,96
 52,80 M 2

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,20 -€ 0,27 -35,0%
Q32025 -€ 0,20 -€ 0,21 -5,0%
Q22025 -€ 0,20 -€ 0,21 -5,0%
Q12025 -€ 0,16 -€ 0,22 -37,5%

ETFs Holding This Stock

BRUSX BRUSX
0,79% weight
IRSSX IRSSX
0,02% weight
PSGIX PSGIX
0,02% weight
CSGEX CSGEX
0,02% weight
TMFX TMFX
0,02% weight
VVICX VVICX
0,01% weight
IIRSX IIRSX
0,01% weight
IRCIX IRCIX
0,01% weight
IRSIX IRSIX
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 17,78% Revenue Growth (3Y) 24,23%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 22,72% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 36,97 M Net Income (TTM) -25,54 M
ROE -143,41% ROA -41,45%
Gross Margin 61,38% Operating Margin -65,36%
Net Margin -69,08% Free Cash Flow (TTM) -24,45 M
ROIC -35,42% FCF Growth (3Y) N/A
Safety
Debt / Equity 1,84 Current Ratio 6,37
Interest Coverage -10,12 Asset Turnover 0,60
Working Capital 43,28 M Tangible Book Value 15,87 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -10,46 Forward P/E -10,65
P/B Ratio 16,83 P/S Ratio 7,23
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 4,23 Fwd Earnings Yield N/A
FCF Yield -9,15%
Market Cap 267,14 M Enterprise Value 258,12 M
Per Share
EPS (Diluted TTM) -0,90 Revenue / Share 1,24
FCF / Share -0,82 OCF / Share -0,80
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,41% FCF Conversion 95,72%
SBC-Adj. FCF -32,55 M Growth Momentum -4,94

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 36,97 M 31,39 M 23,96 M 20,55 M 16,30 M
Net Income -25,54 M -18,91 M -22,09 M -16,44 M -14,41 M
EPS (Diluted) -0,90 -0,70 -0,90 -0,68 —
Gross Profit 22,69 M 19,12 M 13,61 M 13,53 M 11,29 M
Operating Income -24,16 M -19,75 M -22,45 M -16,33 M -13,37 M
EBITDA — — — — —
R&D Expenses 13,90 M 12,39 M 11,71 M 10,89 M 8,99 M
SG&A Expenses 16,50 M 12,00 M 11,76 M 9,61 M 8,76 M
D&A 814.000,0 980.000,0 626.000,0 244.000,0 159.000,0
Interest Expense 2,39 M 872.000,0 386.000,0 81.000,0 973.000,0
Income Tax 55.000,0 12.000,0 8.000,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 97,75 M 39,19 M 42,66 M 55,49 M 65,58 M
Total Liabilities 69,73 M 13,80 M 21,49 M 18,60 M 16,79 M
Shareholders' Equity 28,02 M 25,39 M 21,17 M 36,89 M 48,79 M
Total Debt 49,08 M — 9,95 M 9,89 M 9,84 M
Cash & Equivalents 45,92 M 20,10 M 23,14 M 27,62 M 54,11 M
Current Assets 63,60 M 33,36 M 36,17 M 51,18 M 61,89 M
Current Liabilities 10,77 M 10,35 M 7,43 M 6,79 M 4,75 M